Assertio Holdings (ASRT) Common Equity (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Common Equity came in at $75.6 million in Q1 2026, down 30.31% year-on-year from $108.5 million in Q1 2025, and down 19.5% quarter-over-quarter from $94.0 million in Q4 2025.
Assertio Holdings (ASRT) Common Equity (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Common Equity across 8 years of filings, most recently posting $75.6 million for Q1 2026.
- Common Equity for Q1 2026 came in at $75.6 million, down 30.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.6 million (down 30.31% YoY), and the FY2025 annual result was $94.0 million, down 22.41% from the prior year.
- Common Equity came in at $75.6 million for Q1 2026 at Assertio Holdings, down from $94.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $254.3 million in Q2 2023 to a low of $75.6 million in Q1 2026.
- The 5-year median for Common Equity is $130.5 million (2024), against an average of $143.1 million.
- Across the five-year window, Common Equity surged 124.08% in 2023 and sank 48.03% in 2024, its largest moves.
- Assertio Holdings' Common Equity stood at $225.7 million in 2022, then tumbled by 38.86% to $138.0 million in 2023, then declined by 12.26% to $121.1 million in 2024, then declined by 22.41% to $94.0 million in 2025, then declined by 19.5% to $75.6 million in 2026.
- The last three Common Equity figures came in at $75.6 million (Q1 2026), $94.0 million (Q4 2025), and $105.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 75.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.63 Mn |
| Dec 31, 2025 | 93.95 Mn |
| Sep 30, 2025 | 105.80 Mn |
| Jun 30, 2025 | 93.30 Mn |
| Mar 31, 2025 | 108.53 Mn |
| Dec 31, 2024 | 121.08 Mn |
| Sep 30, 2024 | 130.52 Mn |
| Jun 30, 2024 | 132.15 Mn |
| Mar 31, 2024 | 134.49 Mn |
| Dec 31, 2023 | 138.00 Mn |
| Sep 30, 2023 | 192.87 Mn |
| Jun 30, 2023 | 254.27 Mn |
| Mar 31, 2023 | 250.66 Mn |
| Dec 31, 2022 | 225.73 Mn |
| Sep 30, 2022 | 134.92 Mn |
| Jun 30, 2022 | 128.37 Mn |
| Mar 31, 2022 | 111.86 Mn |
| Dec 31, 2021 | 102.41 Mn |
| Sep 30, 2021 | 96.86 Mn |
| Jun 30, 2021 | 92.27 Mn |